Next Article in Journal
Mitochondrial Signaling and Ultrastructure in the Myocardium During Long-Term Adaptation to Hypoxia
Previous Article in Journal
Integrative Transcriptomics Uncovers IFN-β Signature and IFITM3 as Putative Molecular Mediator in MS
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 27
Issue 12
10.3390/ijms27125330
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

MicroRNAs as Biomarkers of Cervical Cancers

by
Wojciech Jelski
1,*,
Sylwia Okrasinska
2,
Jan Mroczko
1,
Weronika Rutkowska
2,
Klaudia Zieziula
2 and
Barbara Mroczko
1,3
1
Department of Biochemical Diagnostics, Medical University, 15-269 Bialystok, Poland
2
Department of Biochemical Diagnostics, University Hospital, 15-269 Bialystok, Poland
3
Department of Neurodegeneration Diagnostics, Medical University, 15-269 Bialystok, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(12), 5330; https://doi.org/10.3390/ijms27125330 (registering DOI)
Submission received: 4 May 2026 / Revised: 10 June 2026 / Accepted: 10 June 2026 / Published: 12 June 2026
(This article belongs to the Special Issue Protein Biomarkers in Cancer and Neurodegeneration)
Versions Notes

Abstract

Invasive cervical cancer is a very common cause of cancer death in women worldwide, primarily due to late detection of this cancer. The clinical manifestations of cervical cancer vary significantly and are difficult to predict. Finding new effective biomarkers for the early detection of cervical cancer is essential to reducing mortality. Small microRNA molecules have also recently emerged as potential biomarker candidates in the diagnosis of cervical cancer. Despite analytical limitations in microRNA assays and the lack of automated and standardized tests, validated and prospective systematic evaluation of this new parameter in cervical cancer deserves further development. This review describes the importance and potential usefulness of microRNAs in detecting cervical cancer at an early stage, monitoring the course of the disease, and assessing the effectiveness of treatment. The diagnostic importance of microRNAs is well documented in many publications, suggesting that, as microRNA research progresses, they may become a useful diagnostic tool for cervical cancer.
Keywords: microRNA; cervical cancer; biomarker microRNA; cervical cancer; biomarker

Share and Cite

MDPI and ACS Style

Jelski, W.; Okrasinska, S.; Mroczko, J.; Rutkowska, W.; Zieziula, K.; Mroczko, B. MicroRNAs as Biomarkers of Cervical Cancers. Int. J. Mol. Sci. 2026, 27, 5330. https://doi.org/10.3390/ijms27125330

AMA Style

Jelski W, Okrasinska S, Mroczko J, Rutkowska W, Zieziula K, Mroczko B. MicroRNAs as Biomarkers of Cervical Cancers. International Journal of Molecular Sciences. 2026; 27(12):5330. https://doi.org/10.3390/ijms27125330

Chicago/Turabian Style

Jelski, Wojciech, Sylwia Okrasinska, Jan Mroczko, Weronika Rutkowska, Klaudia Zieziula, and Barbara Mroczko. 2026. "MicroRNAs as Biomarkers of Cervical Cancers" International Journal of Molecular Sciences 27, no. 12: 5330. https://doi.org/10.3390/ijms27125330

APA Style

Jelski, W., Okrasinska, S., Mroczko, J., Rutkowska, W., Zieziula, K., & Mroczko, B. (2026). MicroRNAs as Biomarkers of Cervical Cancers. International Journal of Molecular Sciences, 27(12), 5330. https://doi.org/10.3390/ijms27125330

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop